Anti‐Jk^a that are detected by solid‐phase red blood cell adherence but missed by gel testing can cause hemolytic transfusion reactions

Abstract

SPRCA testing significantly increased the discovery of clinically significant anti-Jk^a and facilitated the earlier use of Jk(a-) RBCs to avoid hemolytic transfusion reactions.